Literature DB >> 31720785

Alternative complement pathway is activated in the brains of scrapie-infected rodents.

Cao Chen1,2, Yan Lv1, Chao Hu1, Xiao-Feng Xu1, Ren-Qing Zhang1, Kang Xiao1, Yue Ma1, Li-Ping Gao1, Jian-Le Li1, Qiang Shi1, Jing Wang1, Qi Shi1, Xiao-Ping Dong3,4,5,6.   

Abstract

Activation of complement system in central nervous system (CNS) of the patients suffering from prion diseases or animal models infected with prion agents experimentally is reported repeatedly, but which pathways are involved in the complement system during prion infection is not well documented. Here, we evaluated the level of complement factor B (CFB), which is the key factor that triggers alterative pathway (AP) of complement in the brain tissues of scrapie-infected mice with various methodologies. We found that the levels of mRNA and protein of CFB significantly increased in the brain tissues of scrapie-infected mice. Morphologically, the increased CFB-specific signal overlapped with the elevated C3 signal in brain sections of scrapie-infected mice, meanwhile overlapped with damaged neurons and activated microglia, but not with the proliferative astrocytes. Additionally, the level of complement factor P (CFP), the key positive regulator of AP, also increased remarkably in the brain tissues of infected mice. The transcriptional levels of CD55 and CD46, two negative regulators of AP, decreased without significance in brain tissues of scrapie-infected mice at the terminal stage. However, the mRNA and protein levels of CFH, another negative regulator of AP, increased. Through the dynamic analyses of the expressions of CFB, CFP, and CFH in brain sections of 139A-infected mice, which were collected at different time-points during incubation period, illustrated time-dependent increase levels of each factor during the incubation period of scrapie infection. Taken together, our data here demonstrate that the AP of complement cascade is activated in the CNS microenvironment during prion infection.

Entities:  

Keywords:  CFB; CFH; CFP; Complement; Prion

Mesh:

Substances:

Year:  2019        PMID: 31720785     DOI: 10.1007/s00430-019-00641-6

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  35 in total

1.  The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.

Authors:  Andreas Sjöberg; Patrik Onnerfjord; Matthias Mörgelin; Dick Heinegård; Anna M Blom
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

2.  Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

Authors:  S K Singhrao; J W Neal; B P Morgan; P Gasque
Journal:  Exp Neurol       Date:  1999-10       Impact factor: 5.330

Review 3.  Complement factor H-ligand interactions: self-association, multivalency and dissociation constants.

Authors:  Stephen J Perkins; Ruodan Nan; Keying Li; Sanaullah Khan; Ami Miller
Journal:  Immunobiology       Date:  2011-10-28       Impact factor: 3.144

Review 4.  Complement in the brain.

Authors:  Robert Veerhuis; Henrietta M Nielsen; Andrea J Tenner
Journal:  Mol Immunol       Date:  2011-05-04       Impact factor: 4.407

5.  Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue.

Authors:  Daniel A Mitchell; Louise Kirby; Susan M Paulin; Christian L Villiers; Robert B Sim
Journal:  Mol Immunol       Date:  2007-03-06       Impact factor: 4.407

6.  Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.

Authors:  Azubuike I Okemefuna; Ruodan Nan; Ami Miller; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

7.  Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 8.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease.

Authors:  T Ishii; S Haga; S Yagishita; J Tateishi
Journal:  Appl Pathol       Date:  1984

Review 10.  The complement system in prion diseases.

Authors:  Neil A Mabbott
Journal:  Curr Opin Immunol       Date:  2004-10       Impact factor: 7.486

View more
  3 in total

1.  Different Aberrant Changes of mGluR5 and Its Downstream Signaling Pathways in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents.

Authors:  Chao Hu; Cao Chen; Ying Xia; Jia Chen; Wei Yang; Lin Wang; Dong-Dong Chen; Yue-Zhang Wu; Qin Fan; Xiao-Xi Jia; Kang Xiao; Qi Shi; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Front Cell Dev Biol       Date:  2022-05-12

Review 2.  Neuroinflammation in Prion Disease.

Authors:  Bei Li; Meiling Chen; Caihong Zhu
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

3.  Toxoplasma Infection Induces Sustained Up-Regulation of Complement Factor B and C5a Receptor in the Mouse Brain via Microglial Activation: Implication for the Alternative Complement Pathway Activation and Anaphylatoxin Signaling in Cerebral Toxoplasmosis.

Authors:  Noriko Shinjyo; Kenji Hikosaka; Yasutoshi Kido; Hiroki Yoshida; Kazumi Norose
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.